Overview

Global Veterinary Vaccines Market is estimated to value over USD 4.5 billion by 2026 end and register a CAGR of over 13% during the forecast period 2019 to 2026.

 

Rising incidences of livestock epidemics, increasing population of livestock and rising prevalence of zoonotic diseases are steering the global veterinary vaccines market growth. Rising awareness with regards to the commercial vaccines is responsible for the increasing adoption worldwide.

This market is one of the lucrative alternatives of investments seeking attention and investments from both non-government and government key players. The shifting emphasis on healthy animal husbandry and an increasing number of pet owners are other important factors boosting the market proliferation. The intervention of the government in channel distribution whereas, it is affecting the overall profits incurred by the manufacturers of the veterinary vaccines.

Attenuated vaccines segment dominated the market owing to advantages, for instance, enhanced long-term prevention and improved effectivity. Cattle vaccinations held the largest global veterinary vaccines market share owing to the rise in the insistence for safe and effective animal products. The companion animal vaccines are currently proliferating due to an increase in the number of pet ownerships across the world. The North American region subjugated the market in 2018. Rising animal product commercialization and increasing awareness regarding the health of animals are prime reasons for the region’s domination over the forecast period. The Asia Pacific region is predicted to exhibit rapid augmentation during the forecast timeframe due to faster adoption of animal vaccines for better animal health and high-quality food products.

 

Key market players included in the global veterinary vaccines industry are Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Virbac, Vetoqunol, Phibro Animal Health, Hester, Hipra, Biologika, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry, Jinyu Bio-Technology.

 

Global Veterinary Vaccines Market Segmentation:

By Type

  • Porcine Vaccines 
  • Poultry Vaccines 
  • Livestock Vaccines 

- Bovine Vaccines

- Small Ruminant Vaccines

  • Companion Animal Vaccines 

- Canine Vaccines

- Feline Vaccines

  • Aquaculture Vaccines 
  • Other Animal Vaccines 

By Disease

  • Porcine 
  • Poultry 
  • Livestock 

- Bovine

- Small Ruminants

  • Companion Animals 

- Canine

- Feline

  • Aquaculture 

By Technology

  • Live Attenuated Vaccines
  • Inactivated Vaccines 
  • Toxoid Vaccines 
  • Recombinant Vaccines 
  • Other Vaccines 

By Region

  • Europe
  • North America
  • Asia Pacific
  • Rest of the World

 

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

 

Objectives of the Study:

  • To provide with an exhaustive analysis on the global veterinary vaccines market by type, by disease, by technology and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 970 279 4295

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics